Table 3 Pooled prevalence of multidrug-resistant S. aureus and P. aeruginosa
Study | S. aureus Isolates | Proportion (%) 95% CI | I2 (%) 95% CI | P. aeruginosa Isolates | Proportion (%) 95% CI | I2 (%) 95% CI |
|---|---|---|---|---|---|---|
Yakout et al | 5 | 60.0 (14.66–94.73 | 71.7 (49.3–83.6) | 43 | 16.28 (6.81–30.70) | 78.5 (60.8–88.2) |
Bouharkat et al | 60 | 10.0 (3.76–20.51) | 36 | 8.33 (1.75–22.47) | ||
Guira et al | 23 | 17.39 (4.95–38.78) | 2 | 100.0 (15.81–100.0) | ||
Arfaoui et al | 15 | 53.33 (26.59–78.73) | – | – | ||
Anafo et al | 19 | 26.32 (9.15–51.20) | – | – | ||
Mutonga et al | 14 | 35.71 (12.76–64.86) | 6 | 83.33 (35.88–99.58) | ||
Mashaly et al | 18 | 33.33 (13.34–59.01) | 6 | 83.33 (35.88–99.58) | ||
Anyim et al | 11 | 36.36 (10.93–69.21) | – | – | ||
Atlaw et al | 32 | 28.13 (13.75–46.75) | 24 | 45.83 (25.55–67.18) | ||
Belefquih et al | 42 | 14.29 (5.43–28.54) | 27 | 33.33 (16.52–53.96) | ||
Pario et al | 10 | 60.0 (26.24–87.85) | 12 | 50.00 (21.09–78.91) | ||
Hamid et al | 61 | 6.56 (1.82–15.95) | 35 | 40.00 (23.87–57.89) | ||
Yefou et al | 21 | 14.29 (3.05–36.34) | 20 | 35.00 (15.39–59.22) |